Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case

Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case

BackgroundRearranged during transfection (RET) fusions represent a distinct molecular subset of non-small cell lung cancer (NSCLC) with targeted therapeutic potential. Selpercatinib, a highly selective RET inhibitor, has demonstrated efficacy in various solid tumors harboring RET alterations. Here,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Raffaella Pagliaro, Paola Maria Medusa, Fabiana Vitiello, Luigi Aronne, Susan F. M. Campbell, Fabio Perrotta, Andrea Bianco
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	lung adenocarcinoma RET fusion selpercatinib targeted therapy precision medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1500449/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)
by: Rachel E. Reingold, MD, et al.
Published: (2025-03-01)

Remarkable response to low dose of selpercatinib in a patient with RET-rearranged non-small cell lung cancer
by: Jun Sakakibara-Konishi, et al.
Published: (2025-01-01)

Invasive aspergillosis complicated in a patient with non-small cell lung cancer harboring RET fusion during treatment with RET-TKIs: a case report and literature review
by: Kaidiriye Setiwalidi, et al.
Published: (2024-11-01)

First-line selpercatinib for a patient with RET fusion-positive pulmonary large cell neuroendocrine carcinoma
by: Tatsuru Eihuku, et al.
Published: (2024-01-01)

Intracranial Response to Selpercatinib After Pralsetinib-Induced Disease Progression in Rearranged During Transfection Fusion-Positive Non-Small-Cell Lung Cancer: Case Report
by: Illaa Smesseim, MD, et al.
Published: (2024-12-01)

Case report: Eczematous adverse drug reaction after selpercatinib treatment
by: Bingrun Li, et al.
Published: (2024-12-01)

RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer
by: Charlotte K. Kindt, et al.
Published: (2025-01-01)

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
by: Arianna Marinello, MD, et al.
Published: (2025-03-01)

Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
by: Jiancheng Qian, et al.
Published: (2024-12-01)

Research on detection methods of related substances and degradation products of the antitumor drug selpercatinib
by: Jingjing Xiang, et al.
Published: (2025-01-01)

Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung cancer in China: a real-world retrospective chart review
by: Siyu Lei, et al.
Published: (2024-11-01)

Influence of Different Retting on Hemp Stem and Fiber Characteristics Under the East of France Climate Conditions
by: Aurélie Decker, et al.
Published: (2024-12-01)

Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC
by: Francesca Lucibello, MD, et al.
Published: (2025-01-01)

Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents
by: Vito D’Agnano, et al.
Published: (2024-10-01)

Correlation of pregnancy duration with hemoglobin, Ret-He, IL-6, activin B, and hepcidin levels in healthy women
by: Gilang Nugraha, et al.
Published: (2024-06-01)

A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer
by: Tariq Alqahtani, et al.
Published: (2024-12-01)

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression
by: Hejing Bao, et al.
Published: (2024-11-01)

Genoprettende ret i det danske ungdomskriminalitetsnævn?
by: Katrine Barnekow Rasmussen
Published: (2023-10-01)

Using RET-He and Delta-He in the Sysmex XN-1000V Analyzer to Differentiate Between Chronic Hemorrhagic and Chronic Inflammatory Anemia in Small Animals
by: Alejandro Perez-Ecija, et al.
Published: (2024-11-01)

The Potential Impact of Dietary Fiber Supplementation on Hemoglobin and Reticulocyte Hemoglobin Equivalent (RET-He) Levels in Pregnant Women with Anemia Receiving Oral Iron Therapy in Indonesia
by: Afifah A, et al.
Published: (2025-01-01)

Treatment Outcomes and Toxicities of Multiple Tyrosin Kinase Inhibitors for Metastatic Medullary Thyroid Cancer: A Case Series
by: Marilda Mormando, et al.
Published: (2024-12-01)

Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer
by: Lei Wang, et al.
Published: (2025-01-01)

The effect of high intensity interval swimming training on Glial cell line-derived neurotrophic factor and Rearranged during transfection (RET) gene expression in hippocampal tissue in rats with reserpine induced-Parkinson's disease
by: Sahar Abdolahi, et al.
Published: (2024-01-01)

Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients
by: Suma Choorapoikayil, et al.
Published: (2025-01-01)

Evolution of treatment strategies for solid tumors with RET rearrangement in China and real-world treatment status of Non-small Cell Lung Cancer (NSCLC)
by: An Wang, et al.
Published: (2024-11-01)

Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients
by: Guenda Di Benedetto, et al.
Published: (2025-01-01)

Extraction and characterization of lignocellulosic fiber from Prosopis Juliflora bark: Effects of retting method, fiber particle size and alkali treatment cycle on cellulosic properties
by: Endalkachew Tsegaye Liku, et al.
Published: (2024-12-01)

Skyld, ansvar - og hvad så?
by: Beth Grothe Nielsen
Published: (1987-08-01)

Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational study: a brief report
by: Urpo Kiiskinen, et al.
Published: (2025-02-01)

Detection of genetic mutations in 855 cases of papillary thyroid carcinoma by next generation sequencing and its clinicopathological features
by: Dongliang Shi, et al.
Published: (2024-11-01)

When multiple primary lung cancers express the same rare mutation: a case report
by: Yaqing Han, et al.
Published: (2024-11-01)

Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways
by: Ersilia Nigro, et al.
Published: (2020-01-01)

Association of radiomic features with genomic signatures in thyroid cancer: a systematic review
by: Neila Luciano, et al.
Published: (2024-11-01)

Development of Mechanical Extractor for Utilization of Pineapple Leaf Agro-Waste for Textile Application
by: Laxmi Kanta Nayak, et al.
Published: (2024-12-01)

The frequency of mutations in advanced thyroid cancer in Japan: a single-center study
by: Soji Toda, et al.
Published: (2024-01-01)

Gastroesophageal junction adenocarcinoma. A case report
by: Marcos Félix Osorio Pagola, et al.
Published: (2010-12-01)

Adenocarcinoma of the sublingual salivary gland – A case report
by: Sahana Adirajaiah, et al.
Published: (2012-09-01)

Applicability of a computer retinal model for scale-dependent investigation of legibility problems
by: Gábor Dömötör, et al.
Published: (2025-02-01)

Rearranged During Transfection Rearrangement Detection by Fluorescence In Situ Hybridization Compared With Other Techniques in NSCLC
by: Anne Mc Leer, PhD, et al.
Published: (2024-12-01)

Impact of extraction methods on the properties of Carica papaya pseudostem fibers from Cameroon used as reinforcement in biocomposites
by: Jean Aimé Mono, et al.
Published: (2025-01-01)